北京大学学报(医学版)
北京大學學報(醫學版)
북경대학학보(의학판)
JOURNAL OF BEIJING MEDICAL UNIVERSITY(HEALTH SCIENCES)
2015年
3期
504-508
,共5页
王威%郑磊%刘树铭%黄明伟%石妍%吕晓鸣%张杰%张建国
王威%鄭磊%劉樹銘%黃明偉%石妍%呂曉鳴%張傑%張建國
왕위%정뢰%류수명%황명위%석연%려효명%장걸%장건국
涎腺肿瘤%肿瘤转移%近距离治疗%碘放射性同位素
涎腺腫瘤%腫瘤轉移%近距離治療%碘放射性同位素
연선종류%종류전이%근거리치료%전방사성동위소
Salivary gland neoplasms%Neoplasm metastasis%Brachytherapy%Iodine radioisotopes
目的::探讨唾液腺癌经手术联合125 I粒子治疗后远处转移的一般规律及影响远处转移的临床病理因素。方法:选取2001年10月至2010年3月就诊于北京大学口腔医院经手术联合125 I粒子治疗的唾液腺癌患者197例,总结远处转移的发生特点,应用单因素和多因素方法分析影响远处转移的临床病理因素。结果:远处转移率为14.2%(28/197),常见部位是肺(25/28,89.3%),其次是骨(5/28,17.9%)和肝(4/28,14.3%);诊断至远处转移的时间为5~168个月,平均时间(44.2±45.8)个月,中位时间64个月;远处转移至死亡的时间为0~54个月,平均时间(9.7±13.4)个月,中位时间12个月。3年局部区域控制率和生存率分别为90.8%,87.8%;5年分别为84.0%,81.0%。单因素分析局部区域控制情况(F=26.997,P <0.01)和组织学分型(F=1.592,P<0.01)是唾液腺癌远处转移的危险因素;而性别、年龄、原发部位、T分期、术后淋巴结是否阳性、肿瘤切缘及面神经侵犯情况,与唾液腺癌远处转移无显著关系;多因素分析局部区域控制情况(F=29.332,P<0.01)是影响唾液腺癌远处转移的主要因素。结论:手术联合125 I粒子治疗唾液腺癌,局部控制率高,延长远处转移的发生时间,局部区域控制情况是影响唾液腺癌远处转移的主要因素。
目的::探討唾液腺癌經手術聯閤125 I粒子治療後遠處轉移的一般規律及影響遠處轉移的臨床病理因素。方法:選取2001年10月至2010年3月就診于北京大學口腔醫院經手術聯閤125 I粒子治療的唾液腺癌患者197例,總結遠處轉移的髮生特點,應用單因素和多因素方法分析影響遠處轉移的臨床病理因素。結果:遠處轉移率為14.2%(28/197),常見部位是肺(25/28,89.3%),其次是骨(5/28,17.9%)和肝(4/28,14.3%);診斷至遠處轉移的時間為5~168箇月,平均時間(44.2±45.8)箇月,中位時間64箇月;遠處轉移至死亡的時間為0~54箇月,平均時間(9.7±13.4)箇月,中位時間12箇月。3年跼部區域控製率和生存率分彆為90.8%,87.8%;5年分彆為84.0%,81.0%。單因素分析跼部區域控製情況(F=26.997,P <0.01)和組織學分型(F=1.592,P<0.01)是唾液腺癌遠處轉移的危險因素;而性彆、年齡、原髮部位、T分期、術後淋巴結是否暘性、腫瘤切緣及麵神經侵犯情況,與唾液腺癌遠處轉移無顯著關繫;多因素分析跼部區域控製情況(F=29.332,P<0.01)是影響唾液腺癌遠處轉移的主要因素。結論:手術聯閤125 I粒子治療唾液腺癌,跼部控製率高,延長遠處轉移的髮生時間,跼部區域控製情況是影響唾液腺癌遠處轉移的主要因素。
목적::탐토타액선암경수술연합125 I입자치료후원처전이적일반규률급영향원처전이적림상병리인소。방법:선취2001년10월지2010년3월취진우북경대학구강의원경수술연합125 I입자치료적타액선암환자197례,총결원처전이적발생특점,응용단인소화다인소방법분석영향원처전이적림상병리인소。결과:원처전이솔위14.2%(28/197),상견부위시폐(25/28,89.3%),기차시골(5/28,17.9%)화간(4/28,14.3%);진단지원처전이적시간위5~168개월,평균시간(44.2±45.8)개월,중위시간64개월;원처전이지사망적시간위0~54개월,평균시간(9.7±13.4)개월,중위시간12개월。3년국부구역공제솔화생존솔분별위90.8%,87.8%;5년분별위84.0%,81.0%。단인소분석국부구역공제정황(F=26.997,P <0.01)화조직학분형(F=1.592,P<0.01)시타액선암원처전이적위험인소;이성별、년령、원발부위、T분기、술후림파결시부양성、종류절연급면신경침범정황,여타액선암원처전이무현저관계;다인소분석국부구역공제정황(F=29.332,P<0.01)시영향타액선암원처전이적주요인소。결론:수술연합125 I입자치료타액선암,국부공제솔고,연장원처전이적발생시간,국부구역공제정황시영향타액선암원처전이적주요인소。
Objective:To investigate clinical features of distant metastases ( DM ) and analyze clinico-pathologic risk factors associated with DM from salivary gland carcinomas after being treated by surgery combined with 125 I internal brachytherapy. Methods: Between October 2001 and March 2010, 197 pa-tients with salivary gland carcinoma were treated by surgery combined with 125 I internal brachytherapy and had follow-up for 2 years or more. Univariate and multivariate analyses were performed to evaluate clini-copathologic risk factors that might influence the risk of distant metastases. Results:DM occurred in 28 of 197 patients (14. 2%). The commonest site of distant metastases overall was the lung 89. 3% (25/28), followed by bones 17. 9% (5/28) and liver (4/28). DM developed after an average interval of (44. 2 ± 45. 8) months from the time of initial diagnosis, and the mean interval was 64 months. The average time to death after the diagnosis of DM was only (9. 7 ± 13. 4) months, and the mean time was 12 months. The 3-year locoregional control rate and survival rate were 90. 8%, and 87. 8% respectively,and the 5-year ones 84. 0% and 81. 0%, respectively. Univariate analyses revealed that the risk of distant metasta-ses was significantly influenced by locoregional tumor failure (F=26. 997,P<0. 01) and histologic dif-ferentiation (F=1. 592,P<0. 01). Multivariate analysis of freedom from distant metastases revealed that locoregional control (F=29. 332,P<0. 01) significantly influenced this end point. Conclusion: Sali-vary gland carcinoma could achieve high local control rate after being treated by surgery combined with 125 I internal brachytherapy, and the average interval from diagnosis to DM was prolonged, DM was signifi-cantly influenced bylocoregional control.